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ABSTRACT
Cholangiocarcinoma is a serious problem of public health in the northeastern region of Thailand. Cancer therapies have many
side effects to healthy cells and tissues. Therefore, new anticancer agents are identified from natural resources to decrease
side effects and increase the potential of cancer treatments. Ripe wild mango fruit extract which called 6A* was determined
the cytotoxic effect in cholangiocarcinoma MO55 cells and a normal epithelial cell of the bile duct MMNK1 cells by using
MTT assay. The extract was analyzed total phenolic contents and total flavonoid contents, including screened phytochemical
types. In this study, 6A* displayed cytotoxicity in MO55 cells (IC50 0.40 mg/mL) and low cytotoxicity against MMNK1
cells (IC50 2.70 mg/mL). The total phenolic contents and total flavonoid contents of 6A* were 192.14 ± 30.69 mg GAE/g
extract, and 73.13 ± 6.34 mg QT/g extract, respectively. The study also found that phytochemicals in 6A* contained tannin,
gallic acid, flavonoids, terpenoids, and cardiac glycoside. These molecules could be developed as the new anticancer drugs or
cancer prevention agents for treatment cholangiocarcinoma in the future.
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INTRODUCTION
According to the report of Gotto et al. (2010), the
incidence rate of cancer worldwide and the rate of
human death are increasing significantly (Gotto et
al., 2010). Cholangiocarcinoma (CCA) is a kind of
malignant tumor that has been indicated the
prevalence in Southeast Asia. The highest incidence
in the world of cholangiocarcinoma has been
reported in the northeastern region of Thailand
(Vatanasapt et al., 1990; Sripa et al., 2005).
Therefore, cholangiocarcinoma is an important
problem of public health in this area. There are many
risk factors that associate with CCA, especially,
consumption uncooked freshwater fish which have
the parasite; Opisthorchis viverrini. Metacercaria of
O. viverrini can growth in the bile duct as well. The
originating of CCA may associate with the toxin,
that produced by this parasite.
Moreover, N-nitroso compound and Nitro-
samines contained in fermented fish food products
can enhance CCA progression for short period,
due to people in the northeastern area have a high
risk of CCA more than other regions (Khuntikao
et al., 2005). CCA is difficult to identify because
it was recognized and complicated diseases
(Wasuworawong et al., 2015). Surgery combining
radiotherapy and/or chemotherapy is used for cancer
treatments. However, these methods have been
reported that they have many side effects with
healthy cells and tissues (Lin et al., 2007). More-
over, the resistance of chemotherapeutic drugs of
cancer cells affects cancer treatments (Gatti et al.,
2005). Thus, the side effects and cancer cell
resistance of drugs are the major causes of
unsatisfactory in cancer therapy, to date. To improve
these problems, new anticancer drugs or the process
of cancer preventions have been identified (Hoskin
& Ramamoorthy, 2008).
Additionally, cancer preventions have interested
to decrease the cancer incidences of humans
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worldwide. Functional foods are the target of cancer-
protective sources which are able to reduce free
radicals, moderate immune systems, decrease the
symptom of diseases and enhance the enzyme
functions etc. Plants foods are natural resources of
bioactive compounds that have been reported of the
pharmaceutical properties. Therefore, vegetables and
fruits are promoted to high intake for prevention of
cancer (Chahar et al., 2011; Galati et al., 2000;
Middleton et al., 2000; Yang et al., 2001).
Wild mango (Spondias pinnata (L.f.) Kurz or S.
mangifera Wild or S. acuminate Roxb.) is a
medicinal plant that membered in Genus Spondias,
family Anacardiaceae. Wild mango can grow in a
temperate area and is widely find in Southeast Asia,
including Thailand. It is a dietary plant used as the
ingredient of traditional foods. Various parts of wild
mango have been found the bioactive compounds
which display pharmaceutical properties (Sameh et
al., 2008). Wild mango fruit is used in traditional
medicine for the therapy of many illnesses. The
phytochemical agents in wild mango fruit show the
potential of antioxidant, anti-inflammatory anti-
microbial, including anti-cancer in many kinds of
cancer cells (Sameh et al., 2008). Patathananone
(2017) has reported that the biological activities of
ripe wild mango fruit extract displayed anticancer
activity on oral carcinoma cell lines (KB cells). In
addition, these bioactive compounds exhibited a
very low cytotoxic effect with normal cells (Vero
cells). However, the study on anti-cancer activity in
cholangiocarcinoma of ripe wild mango fruit extract
has not been reported.
Therefore, the aims of this study are; to
determine the cytotoxic effect of phytochemical
components in ripe wild mango fruit extract in
cholangiocarcinoma cells (MO55) compare with
normal epithelial bile duct cell lines (MMNK1)
using MTT assay; to do phytochemical screening,
including total phenolic and total flavonoid contents
analysis and to separate these molecules by thin-
layer chromatography (TLC).
MATERIALS AND METHODS
Plant collection and extractions
Ripe wild mango fruits were washed three times
with water and cleaned by using 70% v/v ethanol.
Next, the plant sample was frozen at -20°C for
overnight. After the seed was removed, pericarps
and fruits were collected and stayed on the ice. The
pericarps and fruits were homogenized by using a
blender for 5 min.  The homogenate was freeze dried
by freeze dryer. The extraction processes were
prepared as in the report of Patathananone et al.
(2019). The extract (10.0 g) of isopropanol solvent
was separated by liquid/liquid extraction. The
separate funnel was shaken 10 min and stayed at
room temperature 30 min for three times. The hexane
and methanol layers were kept and concentrated by
the evaporator. The methanolic part was called 6A*
fraction. This extraction part was placed at -20°C
until the next procedures.
Cell viability assay
Cholangiocarcinoma cell lines (MO55 cells)
and normal epithelial bile duct cells (MMNK1) were
kindly provided by Associate Professor Doctor
Banchob Sripa (Khon Kaen University, Khon Kaen,
Thailand). These cell lines were maintained and
constructed as previously described by Wasuwora-
wong et al. (2015). Both cell lines were cultured in
Dulbecco’s Modified Eagle Medium high-glucose
(DMEM) supplemented with 10% FBS, 100 Units/
mL penicillin and 100 µg/mL streptomycin in T25
cell culture flask, at 37°C under a 5% CO2, 95%
air. Cell viability was determined by 3-(4, 5-
dimethylthiazol-2-yl)-2-5-diphenyltetrazolium
bromide assay (MTT assay) according to Pata-
thananone et al. (2019). After cell trypsinization,
cells were resuspended by using a complete culture
medium. Both cell lines, approximately 6×103 cells/
well, were seeded in a 96-well tissue culture plate
for 24 hr. After this period, cells were treated with
various final concentrations of 6A* at 37°C for 24
and 48 hr. The treatment solution was removed and
then 0.5 mg/mL of MTT solution (0.5 mg/ml in 1X
PBS pH 7.4) was placed into each test well, mixed
gently. The plate was incubated in 37°C for 4 hr
and transferred MTT solution from each well. After
that, 100 µL of DMSO was subjected to dissolve
the formazan crystals. The absorbance value was
measured at 570 nm by using ELISA plate reader
(Verioskan Flash). The percentage of cell viability
was calculated according to Patathananone et al.
(2019).
Total phenolic contents
Bioactive components of 6A* fraction were
analyzed total phenolic contents by reacted with
folin-ciocaltue assay with a slightly modified
method according to Rangsriwong et al. (2009).
Approximately, 3.5 mL of 2.0% w/v Na2CO3
solution was placed into a test tube. After that, 100
µL of different concentration of standard gallic acid
and 6A* fraction was added and mixed. Next, 100
µl of Folin reagent, which was diluted for ten folds,
was subjected to each condition. All reactions were
incubated in the dark at room temperature for 30
min. The absorbance value was detected at 750 nm
by spectrophotometer (Thermo Science, U.S.A.). The
standard curve of gallic acid was used to calculate
total phenolic content in this extracted part.
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Total flavonoid contents
Total flavonoid contents in 6A* were analyzed
by using the method according to Olajire et al.
(2011). Approximately, 1 mL of the extracted sample
(6A*) and different concentrations of standard
quercetin were placed into tubes that contained 4.0
ml of double-distilled water (DDW).
Next, 0.3 ml of 5% w/v NaNO2 was added into
each tube and mixed. All reaction tubes were
incubated at room temperature for 5 min. Then, 0.3
mL of 10.0% w/v AlCl3 was added into a volumetric
flask, mixed and incubated for 6 min. After that,
2.0 mL of 1.0 M NaOH was subjected and adjusted
the volume to 10.0 mL by DDW. These reaction
solutions were measured the absorbance value at
510 nm by UV-Visible spectrophotometer (Thermo
Science, U.S.A.). These absorbance values of
quercetin were plotted as a standard curve for using
the calculation of total flavonoid contents.
Separation of the biological components by thin
layer chromatography (TLC)
Phytochemical compounds in 6A* fraction were
separated by TLC. Gallic acid, quercetin, and tannic
acid were spotted on silica sheet for using as the
standard agents. The silica sheet was placed in the
mobile phase chamber which contained chloroform:
methanol+H2O (1:1:0.05). Then, the separated silica
sheets were dried at 105°C for 10 min. The spot of
phytochemical compounds was detected at 256 nm
by a UV detector lamp, including stained with
0.05% anis-aldehyde in acid-methanol.
Screening phytochemical compounds
The phytochemical compounds screening was
studied by modified methods as previously described
by Rangsriwong et al. (2009).
Saponins test
Approximately 1.0 g of 6A* was placed into a
test tube and dissolved by 2.5 mL of 50% v/v
ethanol. It was incubated in a water bath at 60°C
for 5 min. Then, the tube was shaken vigorously.
The positive result was indicated by the appearance
of the bubble.
Tannins test
The 1.0 g of extracted sample (6A*) was
dissolved by 3.0 mL of Deionized water (DI water).
It was incubated in a water bath at 60°C for 5 min.
The precipitant was removed and then 200 µL of the
supernatant was subjected to the tube. Next, a small
volume of 10% w/v ferric chloride was dropped into
the tube and mixed. Tannin was indicated by
presenting of green color or blue-black color.
Determination flavonol, flavanones by cyanidin
reaction
The 1.0 g of sample (6A*) was dissolved in
methanol. The sample solution (1.0 mL) was
subjected to the tube. Concentrated hydrochloric
acid (2.0 mL) was added and mixed gently. Two
small pieces of magnesium (Mg) were placed into a
tube and then shake. The red or orange color
indicated that this extract contained flavonols and
flavanones, flavones.
Terpenoids assay
1.0 mL of supernatant (6A*in dichloromethane)
was added into the test tube. Next, concentrated
H2SO4 at 0.5 mL was placed gently into this tube.
The appearance of the brown ring between both
layers suggested that terpenoids were found.
Detection of steroids
Approximately 1.0 mL of 6A* supernatant was
mixed with 0.5 mL of Glacial acetic acid. After that,
Conc.H2SO4 was added into this reaction tube for
five drops. The positive test was demonstrated by
the exhibition of blue or blue-green color in this
solution.
Cardiac glycosides determination
The extract was dissolved by dichloromethane
and collected the supernatant to analyze the cardiac
glycosides. The filtrated supernatant of this extract
was added into the test tube for 1.0 mL and then
10% w/v FeCl3 has dropped amount 1-2 drops,
mixed. Next, Glacial acetic acid was placed for five
drops into this reaction tube and mixed gently. After
that, 0.5 mL of Conc. H2SO4 was added carefully
into the tube. The brown ring between the layer of
H2SO4 and the extract supernatant demonstrated
that the cardiac glycosides were found.
Statistical analysis
The data were analyzed according to the
statistic method shown in Patathananone et al.
(2016). The absorbance value of each condition was
analyzed by using one-way ANOVA. Post-hoc
Duncan test is a statistical method used to compare
the absorbance value between the groups. The data
showed a mean ± SD of the percentage cell viability.
RESULTS AND DISCUSSION
Anti- cholangiocarcinoma
The 6A* fraction was determined the cytotoxic
effect of cholangiocarcinoma (MO55 cells) and
compared with MMNK 1 cells which is a kind of
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Table 1. IC50 value of 6A* in MO55 and MMNK1 cells
Cell Types
                            IC50 value (mg/ml) of 6A*
24 hr 48 hr
MO55 cells 1.80 0.40
MMNK1 cells > 3.20 2.70
Fig. 1. The comparison of the cytotoxic effect of the bioactive components from 6A* in MO55
and MMNK1 cells incubated for 24 and 48 hr Fig. 1A and 1B. The symbol * displayed significant
data from the control, p < 0.05.
normal bile duct cells. The cytotoxic effect of 6A*
fraction was shown in Figure 1. The bioactive agents
in 6A* fraction also presented the cytotoxic effect
in MO55 cells. The percentage of cell viability was
decreased according to dose-dependence. The IC50
value was indicated in Table 1. On the other hand,
MMNK1 cells represented the percentage of cell
viability higher than MO55 cells. The IC50 dose was
shown in Table 1. The cytotoxic effect comparison
of 6A* was shown in Figure 1(A) and 1(B). These
results indicated that phytochemical components in
6A* displayed the anticancer potential in MO55
cells but showed the very low cytotoxic effect with
MMNK1 cells. The morphological changing of
MO55 and MMNK1 cells were represented in Figure
2(A) and 2(B), respectively. In Figure 3(A), both
cells were treated with 6A* fraction at different
concentrations, which showed 0, 1.6 and 3.2 mg/mL
and incubated for 24 and 48 hr. Negative control or
untreated (0 mg/mL) of both cells were indicated at
the top of the column. The results showed that the
morphological of MO55 cells changed after
incubated with the phytochemicals in 6A* fraction
(indicated by arrow). The number of dead cells
presented higher than the control condition, which
indicated that bioactive agents in 6A* displayed
the cytotoxicity with MO55 cells. Moreover, the
density of cells confluence also decreased after
treated with this sample. These data related to the
percentage of cell viability (Fig. 1(A), 1(B)). On the
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Fig. 2. The morphological changed of MO55 cells (Left column) and MMNK1 cells (Right
column) after incubated with 0, 1.6 and 3.2 mg/mL of 6A* fraction for 24 and 48 hr.
Photography was observed and taken pictures under the inverted microscope that used
magnify power 20×.
other hand, MMNK1 showed more morphological
of healthy cells more than MO55 cells at the same
treatment concentrations. In this study, it was the
first time that we indicated the cytotoxicity of
ripe wild mango fruit extracts in MO55 cells.
Interestingly, this extract showed a low cytotoxic
effect in the normal epithelial bile duct (MMNK1)
cell lines. The result indicated that IC50 value was
2.70 mg/mL for MMNK1 cell at 48 hr. This IC50 dose
was 6-fold higher than the IC50 value that exhibited
in MO55 cells. These results suggested that the
phytochemical compounds in 6A* may have more
affinity binding with cancer cells than normal cells.
It is possible that these bioactive agents may have
the selective ability, leading to the appearance of
cytotoxicity in cancer cells higher than normal
cells. This anti-cancer activity of the phyto-
chemicals in 6A* related to the report described
by Patathananone et al. (2019). These bioactive
agents in 6A* exhibited the cytotoxicity in an oral
carcinoma cell line (KB cells). The IC50 value
showed 1.40 mg/mL for KB cells, which was
incubated by 6A* for 48 hr. Importantly, the
phytochemicals in 6A* displayed low cytotoxicity
in normal fibroblast cells (NHDF cells). The
percentage of cell viability of NHDF cells presented
higher than 80% for treated concentrations. IC50
value for NHDF cells showed higher than 1.6 mg/
mL that was greater than the IC50 dose in KB cells.
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Total phenolic contents/total flavonoid contents
Polyphenolic compounds are the major
secondary metabolites of plants that have been
found more than 8,000 different kinds of poly-
phenols. These phytochemicals are classified into
ten various general subclasses (Bravo, 1998).
Polyphenolic compounds have been reported to
have the spectrum of biological activities such as
antioxidant, antimutagenic, anticarcinogenic, anti-
allergic, anti-inflammatory, and modulation of
enzymatic activities (Chahar et al., 2011; Galati et
al., 2000; Middleton et al., 2000; Yang et al., 2001).
These bioactive agents may have benefits for the
healthcare of humans. Especially, some special
molecules of polyphenols which can develop to be
as chemo-preventive or therapeutic agents against
cancer (Birt et al., 2001). Therefore, in this report,
the total phenolic content in 6A* fraction was
analyzed by folin reagent. Evaluation was base on
standard curve of gallic acid y = 0.0435x – 0.0202,
R2 = 0.99. The total phenolic contents of 6A* were
192.14 ± 30.69 mg GAE/g extract. Moreover,
flavonoids are phytochemical compounds that have
reported the anticancer property in vitro and in
vivo. In this study, total flavonoid contents were
calculated by quercetin equivalent, that represented,
y = 0.0134x + 0.0125, R2 = 0.9998. Total flavonoid
contents were indicated to be 73.13 ± 6.34 mg
QT/g extract. This result suggested that flavonoids
are a big group of phytochemical agents in 6A*
fraction.
Screening bioactive components in 6A* fraction
Qualitative phytochemical screening of 6A*
fraction was observed by different screening
methods. The results were shown in Table 2.
Phenolic, flavonoids, tannin, terpenoids, cardiac
glycoside were found in 6A* fraction. The anti-
cancer property that displayed in 6A* fraction also
related to these molecules. However, these data also
exhibited the screening results of some phyto-
chemicals to explain the possibility of the function
of these compounds. It is necessary to analyze the
bioactive compounds with other techniques.
Thin-layer chromatography
The data which appeared on the silica sheet was
represented in Figure 3. Gallic acid (GA), quercetin
(QT) and tannic acid (TA) were used as the standard
agents. The band of the phytochemical compound
in 6A* fraction showed a similar Rf value with gallic
acid and tannic acid. Tannins are classified into
two groups such as (1) condense tannins and (2)
hydrolysate tannins which are water-soluble
polyphenols. The extracted process that used the
aqueous methanol due to tannins was dissolved and
found in 6A* fraction. This result related to the
result of phytochemicals screening which shows in
Table 2. However, the bioactive agents in 6A*
fraction will be analysed and determined biological
activities, including their structures in the future
work.
Tannins or tannic acids are large complexed
polyphenol. Tannins are exhibited in many dietary
plants. They are used to protect the plant infection
from the plant pathogens, since they can be found
in many parts of plants, including fruits. Tannins
in green tea leave have been suggested as an
anticarcinogenic. Some derivative molecules of
tannins have been exhibited to decrease the
mutagenic activity of a number of mutagens.
Table 2. Phytochemical compounds screening in 6A*
fraction
Screening compounds Results
Polyphenolic/phenolic compound +
Tannin +
Saponin –
Flavonoids +
Flavonols –
Flavanones –
Flavone +
Terpenoids +
Cardiac glycoside +
Steroid –
“+” means present.
“–” means absent.
Fig. 3. Thin layer chromatography (TLC) of 6A* fraction
and standard agents; gallic acid (GA), quercetin (QT),
tannic acid (TA). The separation of substances was detected
by UV lamp at 256 nm (Fig. 3A), while Fig. 3(B) was
developed by 0.05% anis-aldehyde in acid-methanol.
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Moreover, gallic acid is a hydrolysate tannin which
has been presented many biological properties such
as antioxidant, antimicrobial, anti-inflammatory,
including anticancer activity in many kinds of
cancer cell lines. It is used as a food additive and
applied to cancer therapeutic agents (Chung et al.,
1998). Therefore, the inhibitory cholangiocarcinoma
cell growth may associate with these tannin
molecules.
Furthermore, flavonoids are the group of
phytochemicals in 6A* fraction which has total
flavonoids contents around 73.13 ± 6.34 mg QT/g
extract. Previous reports have been indicated that
flavonoids are a class of polyphenols that have been
found more than 4,000 categories (Chahar et al.,
2011). Some flavonoids in tea have shown the
properties of cancer prevention, including induction
apoptotic cell death. Flavonol and flavones are
sub-sub classes of flavonoids which have been
suggested that they can prevent the mutation of the
specific enzyme (Kandaswami et al., 2005). Hirano
et al. (1994) reported the anti-cancer ability of 28
flavonoids on human acute myeloid leukemia cell
line HL-60. Genistein, honokiol, machilin A,
matairesinol, and arctigenin had the strongest effects
on this cell line (Chahar et al., 2011; Hirano et al.,
1994). Therefore, anticancer activity on cholangio-
carcinoma could be related to the effects of these
flavonoids. It is possible that some flavonoid
molecules in this report could be applied as the
cancer prevention agents or combination used
with the chemotherapeutic substances for cancer
treatment.
Moreover, terpenoids are biological agents
which presented in 6A* fraction. These molecules
may be able to inhibit cholangiocarcinoma cell
growth in vitro. Terpenoids are major food
constituents derived from vegetables, fruits, and
different plant food species. The structures of
terpenoids have 4 structure-wise such as mono-
terpenoids, sesquiterpenoids, diterpenoids, tri-
terpenoids, and tetraterpenoids. The most anticancer
property has been found in triterpenoids. However,
the mode of action of terpenoids for anticancer
remains unclear (Thoppil, and Bishayee, 2011;
Salminena et al., 2008; Huang et al., 2012). The
future work, bioactive molecules of terpenoids in
ripe wild mango fruit extracts which presented
anticancer ability will be analyzing the molecular
mechanism.
In addition, cardiac glycosides are a group of
phytochemical components represented in 6A*
fraction. Cardiac diseases have been treated by
cardiac glycosides for more than 200 years. Previous
reports have been suggested that there are some
kinds of cardiac glycoside that may display anti-
cancer activity. Moreover, three cardiac glycosides
have been applied for the therapy of cancer.
Interestingly, they were studied about dose-limiting
toxicities, including maximum tolerated dose in
phase 1 clinical trial, to date (Slingerland et al.,
2013). Therefore, the anticancer activity in
cholangiocarcinoma of 6A* fraction may associate
with the appearance of cardiac glycosides. However,
this data will be supported by future studies.
Overall, the bioactive compounds in ripe wild
mango fruit extract presented anticancer activity in
cholangiocarcinoma. However, they showed a very
low cytotoxic effect with normal (MMNK1) cell
lines. Phytochemical compounds which showed the
selective ability between cancer cells and normal
cells is the goal target for safe applications.
Bioactive agents have been reported of the varieties
of anticancer mechanism. The bioactive com-
ponents which contained in 6A* fraction will be
investigated of the structure and mode of action in
cholangiocarcinoma. These compounds could be
developed as a food supplement, anticancer drugs
to prevent and treat cancer progression.
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